Sellar and Supra-sellar Mass Lesion Imaging Consistent Pituitary Macroadenoma In 70 Year Old Woman: A Case Report

Background: In the sellar region, pituitary tumors are frequent. Clinically evident pituitary lesions account for around 10% of all intracranial lesions, whereas incidental pituitary tumors are found in about 11% of people. Benign adenomas are the most common kind of pituitary tumor. These adenomas are generally tiny when they appear first and manifest early as a hormonal imbalance occurs due to overproduction. A commonly used treatment for adenomas is the excision of the tumor. If metastasis occurs, chemotherapy/radiotherapy can be used. The most common complication of pituitary adenoma is transient or permanent diabetes insipid us, CSF rhinorrhea, or visual field defects.

Case Presentation: We herein present an interesting case of a 70-year-old female patient of the department of neurosurgery. A patient came on an outpatient basis with a clinical history of severe headache in the last 15 days, blurring of vision in bilateral eyes, diplopia and fainting in the previous 8-10 days, fever (on and off) in the past 8 days. The diagnosis was done with the help of CT and MRI scan imaging and treated with excision of adenoma. Many malignancies can be prevented by making specific lifestyle modifications (such as staying at a healthy weight or quitting smoking). However, no known outside risk factors have been associated with pituitary tumors. As a result, at this moment, there is no known strategy to avoid these adenomas other than early intervention.

Conclusion: A case of sellar and supra-sellar mass lesion-imaging consistent with pituitary macroadenoma in 70-year-old women managed with a multicentric approach. Genetic counseling and psychological assistance should be provided to the members of the family. The presenting with pituitary adenoma is part of a genetic condition. With further information on adenohypophyseal cytodifferentiation pathways, the classification of these cancer is expected to improve in the future.